Skip to main content

Advertisement

SpringerLink
Log in

Interstitial cystitis patients’ use and rating of complementary and alternative medicine therapies

  • Original Article
  • Published:
International Urogynecology Journal Aims and scope Submit manuscript

Abstract

Introduction and hypothesis

The purpose of this study was to describe the use of complementary and alternative medicine (CAM) therapies among interstitial cystitis (IC) patients, patients’ perception of CAM therapies’ effectiveness, and the association of time since diagnosis with perceived effectiveness of these therapies.

Methods

In April 2009, the Interstitial Cystitis Association (ICA) initiated an Internet-based survey on CAM. Respondents indicated whether they received an IC diagnosis and how long ago, whether they tried CAM, and who recommended it. On a 5-point scale, respondents rated 49 therapies. For respondents confirming a diagnosis, we used a chi-square goodness-of-fit test to assess which therapies were rated positively or negatively by a majority of patients who tried them. Using separate one-way analyses of variance, we assessed differences in mean perceived effectiveness among groups based on time since diagnosis and conducted post hoc tests, if necessary. Using chi-square tests, we explored the association of time since diagnosis with the use of CAM and the number of therapies tried.

Results

A total of 2,101 subjects responded to the survey; 1,982 confirmed an IC diagnosis. Most (84.2 %) had tried CAM, and 55 % said physicians had recommended CAM. Of those trying CAM, 82.8 % had tried diet or physical therapy and 69.2 % other therapies. Of the therapies, 22 were rated positively and 20 negatively; 7 were inconclusive. Therapies patients perceived to be helpful included dietary management and pain management adjuncts such as physical therapy, heat and cold, meditation and relaxation, acupuncture, stress reduction, exercise, and sleep hygiene. Many therapies worked better for those diagnosed recently than for those diagnosed long before.

Conclusions

Randomized, placebo-controlled studies are needed to demonstrate which therapies may indeed control IC symptoms and help send research in new and productive directions.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Abbreviations

ANOVA:

Analysis of variance

CAM:

Complementary and alternative medicine

IC:

Interstitial cystitis

ICA:

Interstitial Cystitis Association

NIDDK:

National Institute of Diabetes and Digestive and Kidney Diseases

References

  1. Hanno P, Dmochowski R (2009) Status of international consensus on interstitial cystitis/bladder pain syndrome/painful bladder syndrome: 2008 snapshot. Neurourol Urodyn 28:274–286

    Article  PubMed  Google Scholar 

  2. Theoharides TC, Whitmore K, Stanford E, Moldwin R, O’Leary MP (2008) Interstitial cystitis: bladder pain and beyond. Expert Opin Pharmacother 9(17):2979–2994

    Article  PubMed  CAS  Google Scholar 

  3. Interstitial Cystitis Association (2010) Doctor’s forum: you’ve come a long way IC treatment. ICA Update, Summer, p 16–22

  4. Barnes PM, Bloom B, Nahin R. CDC National Health Statistics Report #12. Complementary and alternative medicine use among adults and children: United States, 2007. December 10, 2008

  5. Shorter B, Lesser M, Moldwin RM, Kushner L (2007) Effect of comestibles on symptoms of interstitial cystitis. J Urol 178(1):145–152

    Article  PubMed  Google Scholar 

  6. Hanno PM, Burks DA, Clemens JQ, Dmochowski RB, Erickson D, FitzGerald MP, Forrest JB, Gordon B, Gray M, Mayer RD, Newman D, Nyberg Jr L, Payne CK, Wesselmann U, Faraday MM. American Urological Association (AUA) Guideline: diagnosis and treatment of interstitial cystitis/painful bladder syndrome. Preliminary IC/BPS clinical Guideline. Available via http://www.auanet.org/content/guidelines-and-quality-care/clinical-guidelines/main-reports/ic-bps/diagnosis_and_treatment_ic-bps.pdf. Accessed 14 Dec 2011

  7. Payne C, Fitzgerald MP, Burks D et al (2010) Randomized multicenter trial shows efficacy of myofascial physical therapy in women with interstitial cystitis/painful bladder syndrome (IC/PBS). Presented at: American Urological Association 2010 Annual Meeting, 29 May-10 June 2010, San Francisco

  8. Hill JR, Isom-Batz G, Panagopoulos G, Zakariasen K, Kavaler E (2008) Patient perceived outcomes of treatments used for interstitial cystitis. Urology 71(1):62–66

    Article  PubMed  Google Scholar 

  9. Bassaly R, Downes K, Hart S (2011) Dietary consumption triggers in interstitial cystitis/bladder pain syndrome patients. Female Pelvic Med Reconstr Surg 17(1):36–39

    Article  PubMed  Google Scholar 

  10. Giordano J, Schatman ME (2008) A crisis in chronic pain care: an ethical analysis. Part three: toward an integrative, multi-disciplinary pain medicine built around the needs of the patient. Pain Physician 11(6):775–784

    PubMed  Google Scholar 

  11. Astin JA (2004) Mind-body therapies for the management of pain. Clin J Pain 20(1):27–32

    Article  PubMed  Google Scholar 

  12. Trappe HJ (2009) Music and health–what kind of music is helpful for whom? What music not? Dtsch Med Wochenschr 134(51–52):2601–2606

    Article  PubMed  Google Scholar 

  13. Whitmore KE (2002) Complementary and alternative therapies as treatment approaches for interstitial cystitis. Rev Urol 4(Suppl 1):S28–S35

    PubMed  Google Scholar 

  14. Bologna RA, Gomelsky A, Lukban JC, Tu LM, Holzberg AS, Whitmore KE (2001) The efficacy of calcium glycerophosphate in the prevention of food-related flares in interstitial cystitis. Urology 57(6 Suppl 1):119–120

    Article  PubMed  CAS  Google Scholar 

  15. Theoharides TC, Kempuraj D, Vakali S, Sant GR (2008) Treatment of refractory interstitial cystitis/painful bladder syndrome with CystoProtek–an oral multi-agent natural supplement. Can J Urol 15(6):4410–4414

    PubMed  CAS  Google Scholar 

  16. Plotnikoff GA, Quigley JM (2003) Prevalence of severe hypovitaminosis D in patients with persistent, nonspecific musculoskeletal pain. Mayo Clin Proc 78(12):1463–1470

    Article  PubMed  Google Scholar 

  17. Badalian SS, Rosenbaum PF (2010) Vitamin D and pelvic floor disorders in women: results from the National Health and Nutrition Examination Survey. Obstet Gynecol 115(4):795–803

    Article  PubMed  CAS  Google Scholar 

  18. Missmer SA, Chavarro JE, Malspeis S, Bertone-Johnson ER, Hornstein MD, Spiegelman D, Barbieri RL, Willett WC, Hankinson SE (2010) A prospective study of dietary fat consumption and endometriosis risk. Hum Reprod 25(6):1528–1535

    Article  PubMed  CAS  Google Scholar 

  19. Moayyedi P (2010) ACP Journal Club: probiotics improve symptoms in adults with the irritable bowel syndrome. Ann Intern Med 153(6):JC3–JC7

    Google Scholar 

  20. Hoesl CE, Altwein JE (2005) The probiotic approach: an alternative treatment option in urology. Eur Urol 47(3):288–296

    Article  PubMed  CAS  Google Scholar 

  21. Martinez RC, Franceschini SA, Patta MC, Quintana SM, Candido RC, Ferreira JC, De Martinis EC, Reid G (2009) Improved treatment of vulvovaginal candidiasis with fluconazole plus probiotic Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14. Lett Appl Microbiol 48(3):269–274

    Article  PubMed  CAS  Google Scholar 

  22. Interstitial Cystitis Association (2010) Antiyeast treatment for IC: legitimate CAM or hopeful scam? ICA Update, Fall, p 14–17

  23. Nickel JC, Kaufman DM, Zhang HF, Wan GJ, Sand PK (2008) Time to initiation of pentosan polysulfate sodium treatment after interstitial cystitis diagnosis: effect on symptom improvement. Urology 71(1):57–61

    Article  PubMed  Google Scholar 

  24. The ME Association. Managing my M.E. What people with ME/CFS and their carers want from the UK’s health and social services: the results of the ME Association’s major survey of illness management requirements. The ME Association 2010, Gawcott, UK. Available via http://www.mecfs-vic.org.au/sites/www.mecfs-vic.org.au/files/Resource-2010MEAssociation.pdf. Accessed 12 Dec 2011

Download references

Acknowledgments

Supported by the Interstitial Cystitis Association.

Conflicts of interest

None.

Author information

Authors and Affiliations

  1. Female Pelvic Medicine and Reconstructive Surgery, Drexel University College of Medicine, 207 N. Broad Street, 4th Floor, Philadelphia, PA, 19107, USA

    Peter Gregory O’Hare III & Kristene Whitmore

  2. Interstitial Cystitis Association, Rockville, MD, USA

    Penny Allen, Barbara Gordon & Linda Salin

  3. Pelvic and Sexual Health Institute, Philadelphia, PA, USA

    Amy Rejba Hoffmann

Authors
  1. Peter Gregory O’Hare III
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Amy Rejba Hoffmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Penny Allen
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Barbara Gordon
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Linda Salin
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Kristene Whitmore
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Peter Gregory O’Hare III.

Rights and permissions

Reprints and permissions

About this article

Cite this article

O’Hare, P.G., Hoffmann, A.R., Allen, P. et al. Interstitial cystitis patients’ use and rating of complementary and alternative medicine therapies. Int Urogynecol J 24, 977–982 (2013). https://doi.org/10.1007/s00192-012-1966-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00192-012-1966-x

Keywords

Search

Navigation